CD200/OX2 Antibody (samalizumab) [DyLight 350]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28596UV
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Flow Cytometry, Functional
Label
DyLight 350 (Excitation = 353 nm, Emission = 432 nm)
Antibody Source
Recombinant Monoclonal Human IgG2 Clone # samalizumab
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for CD200/OX2 Antibody (samalizumab) [DyLight 350]
Immunogen
CD200
Clonality
Monoclonal
Host
Human
Isotype
IgG2
Applications for CD200/OX2 Antibody (samalizumab) [DyLight 350]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD200
Alternate Names
CD200, MOX1, MOX2, MRC, OX-2
Gene Symbol
CD200
Additional CD200 Products
Product Documents for CD200/OX2 Antibody (samalizumab) [DyLight 350]
Product Specific Notices for CD200/OX2 Antibody (samalizumab) [DyLight 350]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...